Skip to main content

Day: September 18, 2023

Sandoz receives positive CHMP opinion for breast and gastric cancer biosimilar trastuzumab

Positive CHMP opinion based on comprehensive package of analytical, pre-clinical and clinical dataBreast and gastric cancers are among most common types of cancer, accounting together for nearly half a million new cases every year in Europe alone1,2Sandoz is committed to accelerating access to potentially life-changing treatments and continues to strengthen its oncology and supportive care portfolioBasel, September 18, 2023 — Sandoz, a global leader in generic and biosimilar medicines, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a positive opinion recommending marketing authorization for their biosimilar trastuzumab (150 mg, for intravenous use), developed by EirGenix, Inc. The positive opinion for Sandoz trastuzumab, a monoclonal antibody,...

Continue reading

ALD | LeasePlan releases its strategic plan and financial objectives to 2026

ALD | LeasePlan is releasing today its new “PowerUP 2026” strategic plan. At this occasion, Tim Albertsen, Chief Executive Officer, and the management team will be presenting a detailed overview of ALD | LeasePlan’s ambitions and main strategic operational and financial objectives on 21 September 2023 in Paris.   “PowerUP 2026” strategic plan The “PowerUP 2026” strategic plan follows the recent closing of the LeasePlan acquisition on 22 May 2023, which established ALD | LeasePlan’s leadership position in the mobility sector, well ahead of the ambitions stated in the previous strategic plan, “Move 2025”. ALD | LeasePlan now ranks #1 global multi-brand and multi-channel car leasing player and #1 in 29 countries. Offering the most valuable and innovative products to all client segments, it operated a total fleet of 3.4 million1 fleet as at...

Continue reading

Fluence Selected by Tilt Renewables to Deliver the Latrobe Valley Battery Energy Storage System in Australia

The 100 MW energy storage system will utilise Fluence’s product ecosystem, including Fluence Gridstack™, a 20-year service agreement, Mosaic™ AI-powered bidding software, and Nispera™ asset performance management softwareLatrobe Valley Battery Energy Storage SystemThe Latrobe Valley BESS will be a 100 MW / 200 MWh battery-based energy storage system located south of Morwell in Victoria, Australia.MELBOURNE, Australia, Sept. 18, 2023 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a leading global provider of energy storage products and services, and optimisation software for renewables and storage, today announced that it has been selected by Tilt Renewables to deliver the Latrobe Valley Battery Energy Storage System (BESS). The Latrobe Valley BESS will be a 100 MW / 200 MWh battery-based...

Continue reading

Pipestone Announces That ISS and Glass Lewis Recommend Shareholders Vote “for” Proposed Combination With Strathcona to Create a Leading Canadian Energy Producer, and Sets Record Straight on Flawed and Misleading Arguments by GMT

Voting QR CodeVoting QR CodeCombining with Strathcona is superior to the status quo as it will give Pipestone shareholders the ability to participate in the upside of a much larger, more diversified producer that will benefit from scale, longer-life and better-positioned reserves, improved access to capital and a potential positive re-rating by markets Pipestone’s extensive strategic review process considered all alternatives available to Pipestone, including the arguments and alternatives put forward by GMT, and determined that the combination with Strathcona Resources is in the best interests of Pipestone and the Pipestone shareholders GMT’s efforts to derail a value-unlocking transaction are based on flawed assumptions and misleading arguments and create riskCALGARY, Alberta, Sept. 17, 2023 (GLOBE NEWSWIRE) —  (PIPE...

Continue reading

Vera Bradley Foundation for Breast Cancer Raises $1,513,713 for Breast Cancer Research

FORT WAYNE, Ind., Sept. 17, 2023 (GLOBE NEWSWIRE) — The Vera Bradley Foundation for Breast Cancer (the “Foundation”) today announced a donation of $1,513,713 to support the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine (“IU School of Medicine”). With this gift, the Foundation has funded $40.1 million of breast cancer research to date. In 2022, the Foundation pledged an additional $12.5 million to the IU School of Medicine, bringing the non-profit’s total commitment to breast cancer research to $50 million. The Foundation’s donation announcement was shared at the 29th annual Vera Bradley Foundation for Breast Cancer Classic (the “Classic”), which gathered guests, players, and volunteers from across the country to raise funds for breast cancer research. The multi-day...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.